Amgen Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Amgen Inc. (AMGN) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $45.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-08-05
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for the quarter ending 2026-06-30 was $45.00M, a 25.00% decline year-over-year.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for the quarter ending 2026-03-31 was $35.00M, a 12.50% decline year-over-year.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for the quarter ending 2025-12-31 was $45.00M, a 33.82% decline year-over-year.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for the quarter ending 2025-09-30 was $45.00M, a 12.50% increase year-over-year.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $190.00M, a 1.06% increase from fiscal 2024.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $188.00M, a 4.08% decline from fiscal 2023.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $196.00M, a 29.80% increase from fiscal 2022.
- Amgen Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $151.00M, a 11.70% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 3 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 6 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 9 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|---|---|---|
| 2026-06-30 | $45.00M 10-Q · filed 2026-08-05 | $80.00M 10-Q · filed 2026-08-05 | $125.00M derived: sum of 3 quarters · filed 2026-08-05 | $170.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $35.00M 10-Q · filed 2026-05-01 | $80.00M derived: sum of 2 quarters · filed 2026-05-01 | $125.00M derived: sum of 3 quarters · filed 2026-05-01 | $185.00M derived: sum of 4 quarters · filed 2026-05-01 |
| 2025-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $90.00M derived: sum of 2 quarters · filed 2026-02-13 | $150.00M derived: sum of 3 quarters · filed 2026-02-13 | $190.00M 10-K · filed 2026-02-13 |
| 2025-09-30 | $45.00M 10-Q · filed 2025-11-05 | $105.00M derived: sum of 2 quarters · filed 2025-11-05 | $145.00M 10-Q · filed 2025-11-05 | $213.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $60.00M 10-Q · filed 2025-08-06 | $100.00M 10-Q · filed 2025-08-06 | $168.00M derived: sum of 3 quarters · filed 2026-02-13 | $208.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $40.00M 10-Q · filed 2025-05-02 | $108.00M derived: sum of 2 quarters · filed 2026-02-13 | $148.00M derived: sum of 3 quarters · filed 2026-02-13 | $188.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $108.00M derived: sum of 2 quarters · filed 2026-02-13 | $148.00M derived: sum of 3 quarters · filed 2026-02-13 | $188.00M 10-K · filed 2026-02-13 |
| 2024-09-30 | $40.00M 10-Q · filed 2024-10-31 | $80.00M derived: sum of 2 quarters · filed 2024-10-31 | $120.00M 10-Q · filed 2024-10-31 | $156.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $40.00M 10-Q · filed 2024-08-07 | $80.00M 10-Q · filed 2024-08-07 | $116.00M derived: sum of 3 quarters · filed 2026-02-13 | $166.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $40.00M 10-Q · filed 2024-05-03 | $76.00M derived: sum of 2 quarters · filed 2026-02-13 | $126.00M derived: sum of 3 quarters · filed 2026-02-13 | $176.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $86.00M derived: sum of 2 quarters · filed 2026-02-13 | $136.00M derived: sum of 3 quarters · filed 2026-02-13 | $196.00M 10-K · filed 2026-02-13 |
| 2023-09-30 | $50.00M 10-Q · filed 2023-10-31 | $100.00M derived: sum of 2 quarters · filed 2023-10-31 | $160.00M 10-Q · filed 2023-10-31 | $191.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $50.00M 10-Q · filed 2023-08-04 | $110.00M 10-Q · filed 2023-08-04 | $141.00M derived: sum of 3 quarters · filed 2025-02-14 | $166.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $60.00M 10-Q · filed 2023-04-28 | $91.00M derived: sum of 2 quarters · filed 2025-02-14 | $116.00M derived: sum of 3 quarters · filed 2025-02-14 | $166.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $56.00M derived: sum of 2 quarters · filed 2025-02-14 | $106.00M derived: sum of 3 quarters · filed 2025-02-14 | $151.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $25.00M 10-Q · filed 2022-11-04 | $75.00M derived: sum of 2 quarters · filed 2022-11-04 | $120.00M 10-Q · filed 2022-11-04 | $111.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $50.00M 10-Q · filed 2022-08-05 | $95.00M 10-Q · filed 2022-08-05 | $86.00M derived: sum of 3 quarters · filed 2024-02-14 | $156.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $45.00M 10-Q · filed 2022-04-28 | $36.00M derived: sum of 2 quarters · filed 2024-02-14 | $106.00M derived: sum of 3 quarters · filed 2024-02-14 | $156.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $61.00M derived: sum of 2 quarters · filed 2024-02-14 | $111.00M derived: sum of 3 quarters · filed 2024-02-14 | $171.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $70.00M 10-Q · filed 2021-11-03 | $120.00M derived: sum of 2 quarters · filed 2021-11-03 | $180.00M 10-Q · filed 2021-11-03 | $175.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $50.00M 10-Q · filed 2021-08-04 | $110.00M 10-Q · filed 2021-08-04 | $105.00M derived: sum of 3 quarters · filed 2023-02-09 | $170.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $60.00M 10-Q · filed 2021-04-28 | $55.00M derived: sum of 2 quarters · filed 2023-02-09 | $120.00M derived: sum of 3 quarters · filed 2023-02-09 | $175.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $60.00M derived: sum of 2 quarters · filed 2023-02-09 | $115.00M derived: sum of 3 quarters · filed 2023-02-09 | $165.00M 10-K · filed 2023-02-09 |
| 2020-09-30 | $65.00M 10-Q · filed 2020-10-29 | $120.00M derived: sum of 2 quarters · filed 2020-10-29 | $170.00M 10-Q · filed 2020-10-29 | $225.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $55.00M 10-Q · filed 2020-07-29 | $105.00M 10-Q · filed 2020-07-29 | $160.00M derived: sum of 3 quarters · filed 2022-02-16 | $210.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $50.00M 10-Q · filed 2020-05-01 | $105.00M derived: sum of 2 quarters · filed 2022-02-16 | $155.00M derived: sum of 3 quarters · filed 2022-02-16 | $215.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $105.00M derived: sum of 2 quarters · filed 2022-02-16 | $165.00M derived: sum of 3 quarters · filed 2022-02-16 | $215.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $50.00M 10-Q · filed 2019-10-30 | $110.00M derived: sum of 2 quarters · filed 2019-10-30 | $160.00M 10-Q · filed 2019-10-30 | $148.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $60.00M 10-Q · filed 2019-07-31 | $110.00M 10-Q · filed 2019-07-31 | $98.00M derived: sum of 3 quarters · filed 2021-02-09 | $168.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $90.00M 10-Q · filed 2019-05-01 | $38.00M derived: sum of 2 quarters · filed 2021-02-09 | $108.00M derived: sum of 3 quarters · filed 2021-02-09 | $188.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $18.00M derived: sum of 2 quarters · filed 2021-02-09 | $98.00M derived: sum of 3 quarters · filed 2021-02-09 | $173.00M 10-K · filed 2021-02-09 |
| 2018-09-30 | $70.00M 10-Q · filed 2018-10-31 | $150.00M derived: sum of 2 quarters · filed 2018-10-31 | $225.00M 10-Q · filed 2018-10-31 | $327.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $80.00M 10-Q · filed 2018-07-27 | $155.00M 10-Q · filed 2018-07-27 | $257.00M derived: sum of 3 quarters · filed 2020-02-12 | $377.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $75.00M 10-Q · filed 2018-04-25 | $177.00M derived: sum of 2 quarters · filed 2020-02-12 | $297.00M derived: sum of 3 quarters · filed 2020-02-12 | $407.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $102.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $222.00M derived: sum of 2 quarters · filed 2020-02-12 | $332.00M derived: sum of 3 quarters · filed 2020-02-12 | $447.00M 10-K · filed 2020-02-12 |
| 2017-09-30 | $120.00M 10-Q · filed 2017-10-26 | $230.00M derived: sum of 2 quarters · filed 2017-10-26 | $345.00M 10-Q · filed 2017-10-26 | $435.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $110.00M 10-Q · filed 2017-07-26 | $225.00M 10-Q · filed 2017-07-26 | $315.00M derived: sum of 3 quarters · filed 2019-02-13 | $430.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $115.00M 10-Q · filed 2017-04-27 | $205.00M derived: sum of 2 quarters · filed 2019-02-13 | $320.00M derived: sum of 3 quarters · filed 2019-02-13 | $430.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $205.00M derived: sum of 2 quarters · filed 2019-02-13 | $315.00M derived: sum of 3 quarters · filed 2019-02-13 | $425.00M 10-K · filed 2019-02-13 |
| 2016-09-30 | $115.00M 10-Q · filed 2016-10-28 | $225.00M derived: sum of 2 quarters · filed 2016-10-28 | $335.00M 10-Q · filed 2016-10-28 | $413.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $110.00M 10-Q · filed 2016-07-29 | $220.00M 10-Q · filed 2016-07-29 | $298.00M derived: sum of 3 quarters · filed 2018-02-13 | $423.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $110.00M 10-Q · filed 2016-05-02 | $188.00M derived: sum of 2 quarters · filed 2018-02-13 | $313.00M derived: sum of 3 quarters · filed 2018-02-13 | $423.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $203.00M derived: sum of 2 quarters · filed 2018-02-13 | $313.00M derived: sum of 3 quarters · filed 2018-02-13 | $413.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $125.00M 10-Q · filed 2015-11-02 | $235.00M derived: sum of 2 quarters · filed 2015-11-02 | $335.00M 10-Q · filed 2015-11-02 | $459.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $110.00M 10-Q · filed 2015-08-05 | $210.00M 10-Q · filed 2015-08-05 | $334.00M derived: sum of 3 quarters · filed 2017-02-14 | $424.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $100.00M 10-Q · filed 2015-04-27 | $224.00M derived: sum of 2 quarters · filed 2017-02-14 | $314.00M derived: sum of 3 quarters · filed 2017-02-14 | $414.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $124.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $214.00M derived: sum of 2 quarters · filed 2017-02-14 | $314.00M derived: sum of 3 quarters · filed 2017-02-14 | $379.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | $90.00M 10-Q · filed 2014-10-29 | $190.00M derived: sum of 2 quarters · filed 2014-10-29 | $255.00M 10-Q · filed 2014-10-29 | $350.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $100.00M 10-Q · filed 2014-08-05 | $165.00M 10-Q · filed 2014-08-05 | $260.00M derived: sum of 3 quarters · filed 2016-10-31 | $345.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $65.00M 10-Q · filed 2014-04-30 | $160.00M derived: sum of 2 quarters · filed 2016-10-31 | $245.00M derived: sum of 3 quarters · filed 2016-10-31 | $320.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $95.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $180.00M derived: sum of 2 quarters · filed 2016-10-31 | $255.00M derived: sum of 3 quarters · filed 2016-10-31 | $335.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | $85.00M 10-Q · filed 2013-10-29 | $160.00M derived: sum of 2 quarters · filed 2013-10-29 | $240.00M 10-Q · filed 2013-10-29 | $291.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $75.00M 10-Q · filed 2013-08-06 | $155.00M 10-Q · filed 2013-08-06 | $206.00M derived: sum of 3 quarters · filed 2015-02-19 | $305.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $80.00M 10-Q · filed 2013-05-03 | $131.00M derived: sum of 2 quarters · filed 2015-02-19 | $230.00M derived: sum of 3 quarters · filed 2015-02-19 | $305.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $150.00M derived: sum of 2 quarters · filed 2015-02-19 | $225.00M derived: sum of 3 quarters · filed 2015-02-19 | $300.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | $99.00M 10-Q · filed 2012-11-06 | $174.00M derived: sum of 2 quarters · filed 2012-11-06 | $249.00M 10-Q · filed 2012-11-06 | $320.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $75.00M 10-Q · filed 2012-08-08 | $150.00M 10-Q · filed 2012-08-08 | $221.00M derived: sum of 3 quarters · filed 2014-02-24 | $291.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $75.00M 10-Q · filed 2012-05-08 | $146.00M derived: sum of 2 quarters · filed 2014-02-24 | $216.00M derived: sum of 3 quarters · filed 2014-02-24 | $286.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $141.00M derived: sum of 2 quarters · filed 2014-02-24 | $211.00M derived: sum of 3 quarters · filed 2014-02-24 | $283.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | $70.00M 10-Q · filed 2011-11-04 | $140.00M derived: sum of 2 quarters · filed 2011-11-04 | $212.00M 10-Q · filed 2011-11-04 | $292.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $70.00M 10-Q · filed 2011-08-08 | $142.00M 10-Q · filed 2011-08-08 | $222.00M derived: sum of 3 quarters · filed 2013-02-27 | $302.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $72.00M 10-Q · filed 2011-05-10 | $152.00M derived: sum of 2 quarters · filed 2013-02-27 | $232.00M derived: sum of 3 quarters · filed 2013-02-27 | $287.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $160.00M derived: sum of 2 quarters · filed 2013-02-27 | $215.00M derived: sum of 3 quarters · filed 2013-02-27 | $305.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $80.00M 10-Q · filed 2010-11-08 | $135.00M derived: sum of 2 quarters · filed 2010-11-08 | $225.00M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $55.00M 10-Q · filed 2010-08-09 | $130.00M 10-Q · filed 2010-08-09 | ||
| 2009-12-31 | $302.00M 10-K · filed 2012-02-29 | |||
| 2008-12-31 | $382.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |